Fresenius Medical Care AG (ETR:FME – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €40.39 ($42.07) and traded as high as €45.35 ($47.24). Fresenius Medical Care shares last traded at €44.68 ($46.54), with a volume of 247,059 shares traded.
Fresenius Medical Care Trading Up 0.8 %
The stock’s 50 day moving average price is €45.16 and its 200-day moving average price is €40.52. The company has a quick ratio of 0.80, a current ratio of 1.37 and a debt-to-equity ratio of 82.24. The stock has a market capitalization of $13.08 billion, a PE ratio of 19.85, a PEG ratio of 0.42 and a beta of 0.86.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More
- Five stocks we like better than Fresenius Medical Care
- What is a support level?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What is the S&P/TSX Index?
- DuPont’s Electronics Spinoff: The Start of Something Big
- How to Start Investing in Real Estate
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
